Helicobacter pylori Testing
Customize your policy alerts
Sign up for Blue Cross Blue Shield - New Mexico Policy RPLAB018 alerts
Get alerted when Policy RPLAB018 changes without checking for updates manually.
Monitor payer policy activity
Reimbursement criteria for diagnostic and post-treatment testing for H. pylori for Blue Cross Blue Shield - New Mexico members; applies to providers submitting claims for laboratory/pathology services under this payer.
Urea breath testing or stool antigen testing to document eradication performed at least four weeks post-treatment is included as reimbursable.
Susceptibility testing (culture or nucleic acid based) is reimbursable for refractory H. pylori infection.
Clarified and expanded the adult indications list for noninvasive testing (urea breath or stool antigen) including dyspepsia, PUD, MALT lymphoma, gastric intestinal metaplasia, NSAID/aspirin use, unexplained iron deficiency anemia, ITP, family history of gastric cancer, and first-generation immigrants from high prevalence areas.
Explicit prohibitions: serology for H. pylori is not reimbursable for any age; concurrent multiple-test diagnostic approaches are not reimbursable; testing after recent antibiotics, PPIs, or bismuth is not reimbursable.
Added CPT code 87513 to the procedure code list.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.